Guest guest Posted January 18, 2007 Report Share Posted January 18, 2007 Genetic Polymorphisms Associated With Inflammatory Bowel Disease Do Not Confer Risk for Primary Sclerosing Cholangitis Authors: Karlsen, Tom H.; Hampe, Jochen; Wiencke, e; Schrumpf, ; Thorsby, ; Lie, Benedicte A.; Broomé, Ulrika; Schreiber, Stefan; Boberg, Kirsten Muri Source: The American Journal of Gastroenterology, January 2007 Publisher: Blackwell Publishing Abstract: OBJECTIVES: Approximately 80% of patients with primary sclerosing cholangitis (PSC) of Northern European origin have concurrent inflammatory bowel disease (IBD). The majority have ulcerative colitis, but there is also an association with Crohn's colitis. The pathogenetic link between PSC and IBD is unknown. We aimed to assess whether genetic risk factors in PSC can be identified on the basis of known IBD susceptibility genes and the shared PSC-IBD phenotype. METHODS: CARD15, TLR-4, CARD4, SLC22A4, SLC22A5, DLG5, and MDR1 genes were genotyped in a large cohort of 365 Scandinavian PSC patients and 368 healthy controls using TaqMan technology.   RESULTS:   No significant association between any of the investigated genetic IBD risk variants and overall susceptibility to PSC was observed. Apart from a tendency toward an increased carrier frequency of the mutant CARD15 alleles in PSC patients with concurrent Crohn's disease as compared with healthy controls (15.6%vs 9.0%, P= 0.22), no association with any of the polymorphisms investigated was evident even when considering only PSC patients with concurrent IBD. CONCLUSION:  It seems unlikely that IBD-associated polymorphisms in the CARD15, TLR-4, CARD4, SLC22A4, SLC22A5, DLG5, and MDR1 genes confer susceptibility to PSC. The current knowledge of genetic risk factors in IBD may not contribute to our understanding of molecular mechanisms involved in the pathogenesis of PSC or the IBD phenotype in PSC.   (Am J Gastroenterol 2007;102:115-121) Document Type: Research article   DOI: 10.1111/j.1572-0241.2006.00928.x Affiliations: 1: Medical Department 2: Institute of Immunology, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway 3: Institute for Clinical Molecular Biology, Christian-Albrechts University, Kiel, Germany Barb in Texas - Together in the Fight, Whatever it Takes! Son Ken (32) UC 91 - PSC 99 Listed 7/21 @ Baylor Dallas Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.